One of the most revolutionary tools in cutting-edge medicine is a molecular scalpel so precise that it can modify defective ...

CRISPR Therapeutics’ stock is surging as in-vivo therapies show promise. Learn about CRSP stock's risks, long-term upside, ...

A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...

As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...

The idea that a single-celled bacterium can defend itself against viruses in a similar way as the 1.8-trillion-cell human immune system is still “mind-blowing” for molecular biologist Joshua Modell of ...

In May, a historic moment in science and medicine was captured in a single photo that circulated across news outlets ...

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...

Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile--The AATD ...

CRISPR-based tools can’t easily access the DNA in these organelles, but researchers are finding other ways in.

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

When startup Pairwise launched Conscious Greens, a line of CRISPR-edited mustard greens, consumers got to experience ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...